Avadel Pharmaceuticals Files 8-K on Shareholder Vote Matters
| Field | Detail |
|---|---|
| Company | Avadel Pharmaceuticals PLC |
| Form Type | 8-K |
| Filed Date | Jul 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: AVDL
TL;DR
AVDL filed an 8-K for a shareholder vote. Details TBD.
AI Summary
Avadel Pharmaceuticals PLC filed an 8-K on July 29, 2025, to report the submission of matters to a vote of its security holders. The filing does not contain specific details about the matters to be voted on or any associated financial figures.
Why It Matters
This filing indicates that Avadel Pharmaceuticals is convening a meeting for its shareholders to vote on certain corporate matters, which could impact the company's governance or strategic direction.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose new financial information or significant operational changes.
Key Players & Entities
- AVADEL PHARMACEUTICALS PLC (company) — Registrant
- July 29, 2025 (date) — Date of Report
- Ireland (location) — Jurisdiction of Incorporation
FAQ
What specific matters will be submitted for a vote by Avadel Pharmaceuticals PLC's security holders?
The filing states that matters are being submitted to a vote of security holders, but it does not specify what those matters are.
When is the earliest event reported in this 8-K filing?
The earliest event reported is July 29, 2025, which is also the date of the report.
What is Avadel Pharmaceuticals PLC's primary business sector?
Avadel Pharmaceuticals PLC is in the Pharmaceutical Preparations sector, SIC code 2834.
What is the company's principal executive office address?
The principal executive offices are located at 10 Earlsfort Terrace, Dublin 2, Ireland, D02 T380.
Has Avadel Pharmaceuticals PLC undergone a name change previously?
Yes, the company was formerly known as Flamel Technologies SA, with a date of name change on April 22, 1996.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 29, 2025 regarding AVADEL PHARMACEUTICALS PLC.